Skip to main content

Advertisement

Table 4 Survival analysis

From: Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer

Breed Age (years) Clinical stage (TNM) Survival at ten months Observations
Standard scheme (Dox)
Standard Poodle 12 III Yes Alive without relapse
Maltese bichon 9 III No Death, surgical complications
Dachshund 13 III Yes Alive without relapse
Maltese bichon 7 III No Death, surgical complications
Standard scheme (Dox + I2)
Rottweiler 8 III Yes Alive with relapse; no metastasis
Standard Poodle 12 II Yes Alive without relapse
Standard Poodle 10 III Yes Alive with relapse; no metastasis
Labrador Retriever 10 III Yes Alive without relapse
Standard Poodle 12 V Yes Alive without relapse
Standard Poodle 9 III Yes Alive without relapse
Modified scheme (Dox)
Cocker Spaniel 9 II No Death, transitional cell cancer
Mixed breed 6 II No Euthanasia, suspected metastasis
Cocker Spaniel 8 I Yes Alive without relapse
Chihuahua 5 I Yes Alive without relapse
German Shepherd 7 III No Death, anaplastic cancer
Dalmatian 6 I Yes Alive without relapse
Modified scheme (Dox + I2)
Cocker Spaniel 10 III Yes Alive without relapse
Mixed breed 8 I Yes Alive without relapse
Standard Poodle 11 V No Death, extensive metastasis
Cocker Spaniel 13 III Yes Alive without relapse
Fox terrier Toy 7 I Yes Alive without relapse
Standard Poodle 10 III Yes Alive without relapse
Cocker Spaniel 13 III No Death, pyometra
Standard Poodle 10 II Yes Alive without relapse
Standard Poodle 9 III Yes Alive without relapse
Chihuahua 5 III Yes Alive without relapse
Dachshund 10 III No Death, surgical complications